Characteristics and Lytic Activity of Phage Derived Peptidoglycan Hydrolase, LysSAP8, as a Potent Alternative Biocontrol Agent for Staphylococcus aureus.

Outbreaks of staphylococcal food poisoning (SFP) causing serious human diseases and economic losses have been reported globally. Furthermore, the spread of Staphylococcus aureus with increased resistance to multiple antimicrobial agents is causing serious problems in the food industries and medicine. Here, we isolated an endolysin LysSAP8, as one of the peptidoglycan hydrolase, derived from the bacteriophage SAP8 infecting S. aureus. This endolysin was tagged with a 6×His at the C-terminal of the target protein and purified using affinity chromatography. LysSAP8 demonstrated lytic activity against a broad spectrum of bacteria, which included majority of the staphylococcal strains tested in this study as well as the methicillin-resistant S. aureus (MRSA); however, no such activity was observed against other gram-positive or gram-negative bacteria. Additionally, LysSAP8 could maintain bactericidal activity until 0.1 nM working concentration and after heat treatment at 37°C for 30 min. The ability of LysSAP8 to lyse cells under varying conditions of temperature (4-43°C), pH (3-9), and NaCl concentrations (0-1000 mM), and divalent metal ions (Ca2+, Co2+, Cu2+, Mg2+, Mn2+, Hg2+, and Zn2+) was examined. At the optimized condition, LysSAP8 could disrupt approximately 3.46 log(CFU/ml) of the planktonic cells in their exponential phase of growth within 30 min. In this study, we have suggested that LysSAP8 could be a potent alternative as a biocontrol agent that can be used to combat MRSA.

[1]  Sung-Woo Choi,et al.  Prevalence and Risk Factors for Positive Nasal Methicillin-Resistant Staphylococcus aureus Carriage among Orthopedic Patients in Korea , 2019, Journal of clinical medicine.

[2]  M. Jamal,et al.  Bacteriophages: an overview of the control strategies against multiple bacterial infections in different fields , 2018, Journal of basic microbiology.

[3]  R. Hafidh,et al.  Formation of therapeutic phage cocktail and endolysin to highly multi-drug resistant Acinetobacter baumannii: in vitro and in vivo study , 2018, Iranian journal of basic medical sciences.

[4]  P. G. Choe,et al.  Effects of Phage Endolysin SAL200 Combined with Antibiotics on Staphylococcus aureus Infection , 2018, Antimicrobial Agents and Chemotherapy.

[5]  J. Azeredo,et al.  Characterization of a New Staphylococcus aureus Kayvirus Harboring a Lysin Active against Biofilms , 2018, Viruses.

[6]  Y. Tanji,et al.  Characterization of the Lytic Capability of a LysK-Like Endolysin, Lys-phiSA012, Derived from a Polyvalent Staphylococcus aureus Bacteriophage , 2018, Pharmaceuticals.

[7]  P. Moreillon,et al.  In vitro characterization of PlyE146, a novel phage lysin that targets Gram-negative bacteria , 2018, PloS one.

[8]  C. Hadjichristodoulou,et al.  Prevalence of Staphylococcus aureus and of methicillin-resistant S. aureus (MRSA) along the production chain of dairy products in north-western Greece. , 2018, Food microbiology.

[9]  J. Hennekinne Staphylococcus aureus as a Leading Cause of Foodborne Outbreaks Worldwide , 2018 .

[10]  S. Ryu,et al.  Characterization of a novel endolysin LysSA11 and its utility as a potent biocontrol agent against Staphylococcus aureus on food and utensils. , 2017, Food microbiology.

[11]  Henry C. Lin,et al.  Phage therapy: An alternative to antibiotics in the age of multi-drug resistance , 2017, World journal of gastrointestinal pharmacology and therapeutics.

[12]  N. Jiao,et al.  Isolation and characterization of the first phage infecting ecologically important marine bacteria Erythrobacter , 2017, Virology Journal.

[13]  I. A. Hajam,et al.  Improved lysis efficiency and immunogenicity of Salmonella ghosts mediated by co-expression of λ phage holin-endolysin and ɸX174 gene E , 2017, Scientific Reports.

[14]  Hyunjin Yoon,et al.  Endolysin LysSA97 is synergistic with carvacrol in controlling Staphylococcus aureus in foods. , 2017, International journal of food microbiology.

[15]  Md. Ashraful Hasan,et al.  Genomics dataset on unclassified published organism (patent US 7547531) , 2016, Data in brief.

[16]  Ruopeng Cai,et al.  LysGH15 kills Staphylococcus aureus without being affected by the humoral immune response or inducing inflammation , 2016, Scientific Reports.

[17]  M. Loessner,et al.  Bacteriophage endolysins: applications for food safety. , 2016, Current opinion in biotechnology.

[18]  Xing Ye,et al.  Antibacterial Activity of Stenotrophomonas maltophilia Endolysin P28 against both Gram-positive and Gram-negative Bacteria , 2015, Front. Microbiol..

[19]  Peter C. Fineran,et al.  A century of the phage: past, present and future , 2015, Nature Reviews Microbiology.

[20]  Ran Wang,et al.  Bio-Control of Salmonella Enteritidis in Foods Using Bacteriophages , 2015, Viruses.

[21]  F. Lowy,et al.  Staphylococcus aureus infections: transmission within households and the community. , 2015, Trends in microbiology.

[22]  A. Kabanov,et al.  Bacteriophage phi11 lysin: Physicochemical characterization and comparison with phage phi80α lysin. , 2015, Enzyme and microbial technology.

[23]  M. Loessner,et al.  Evolutionarily distinct bacteriophage endolysins featuring conserved peptidoglycan cleavage sites protect mice from MRSA infection. , 2015, The Journal of antimicrobial chemotherapy.

[24]  J. Moult,et al.  Increasing the stability of the bacteriophage endolysin PlyC using rationale-based FoldX computational modeling. , 2015, Protein engineering, design & selection : PEDS.

[25]  D. Trudil Phage lytic enzymes: a history , 2015, Virologica Sinica.

[26]  M. Sanz‐Gaitero,et al.  Crystal structure of the lytic CHAPK domain of the endolysin LysK from Staphylococcus aureus bacteriophage K , 2014, Virology Journal.

[27]  S. Opal,et al.  A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens , 2013, Virulence.

[28]  Chad W. Euler,et al.  Novel Bacteriophage Lysin with Broad Lytic Activity Protects against Mixed Infection by Streptococcus pyogenes and Methicillin-Resistant Staphylococcus aureus , 2013, Antimicrobial Agents and Chemotherapy.

[29]  Junyoung Kim,et al.  A foodborne outbreak of Staphylococcus aureus associated with fried chicken in Republic of Korea. , 2013, Journal of microbiology and biotechnology.

[30]  M. Loessner,et al.  Bacteriophage endolysins as novel antimicrobials. , 2012, Future microbiology.

[31]  M. Schmelcher,et al.  Staphylococcal Phage 2638A endolysin is lytic for Staphylococcus aureus and harbors an inter-lytic-domain secondary translational start site , 2012, Applied Microbiology and Biotechnology.

[32]  Y. Prasad,et al.  P-27/HP Endolysin as Antibacterial Agent for Antibiotic Resistant Staphylococcus aureus of Human Infections , 2011, Current Microbiology.

[33]  M. Argudín,et al.  Food Poisoning and Staphylococcus aureus Enterotoxins , 2010, Toxins.

[34]  D. Donovan,et al.  LysK CHAP endopeptidase domain is required for lysis of live staphylococcal cells. , 2009, FEMS microbiology letters.

[35]  Joel Dudley,et al.  MEGA: A biologist-centric software for evolutionary analysis of DNA and protein sequences , 2008, Briefings Bioinform..

[36]  Rodrigo Lopez,et al.  Clustal W and Clustal X version 2.0 , 2007, Bioinform..

[37]  Stephen P Bottomley,et al.  Protein expression and refolding--a practical guide to getting the most out of inclusion bodies. , 2004, Biotechnology annual review.

[38]  Thomas L. Madden,et al.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.

[39]  S. Eddy,et al.  tRNAscan-SE: a program for improved detection of transfer RNA genes in genomic sequence. , 1997, Nucleic acids research.